The galanin receptor 2/3 agonist Gal2-11 protects the SN56 cells against β-amyloid25-35 toxicity

Journal of Neuroscience Research

Volumn 88, Issue 5, 2010, Pages 1064-1073

  Pirondi, S ^a   Giuliani, A ^a   Del Vecchio, G ^a   Giardino, L ^a   Hokfelt T ^b   Calzà, Laura ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

amyloid; Caspase 3; Cell toxicity; Galanin; Galanin receptor type 2 3

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; CASPASE 3; CHOLINERGIC RECEPTOR STIMULATING AGENT; GALANIN 2 11 PEPTIDE; GALANIN RECEPTOR 2; GALANIN RECEPTOR 3; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL NUCLEUS; CHOLINERGIC NERVE CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; IN VIVO STUDY; MOUSE; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACETYLCHOLINE; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; APOPTOSIS; BASAL NUCLEUS OF MEYNERT; CASPASE 3; CELL LINE, TRANSFORMED; CHOLINERGIC FIBERS; DNA FRAGMENTATION; GALANIN; MICE; NERVE DEGENERATION; NEURONS; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; RECEPTOR, GALANIN, TYPE 2; RNA, MESSENGER; TIME FACTORS;

EID: 77950173312     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22278     Document Type: Article

References (67)

1. Bartfai T, Hö kfelt T, Langel U. 1993. Galanin-a neuroendocrine peptide. Crit Rev Neurobiol 7:229-274.
2. Berger A, Lang R, Moritz K, Santic R, Hermann A, Sperl W, Kofler B. 2004. Galanin receptor subtype GalR2 mediates apoptosis in SH-SY5Y neuroblastoma cells. Endocrinology 145:500-507.
3. Blurton-Jones M, LaFerla FM. 2006. Pathways by which Abeta facilitates tau pathology. Curr Alzheimer Res 3:437-448.
4. Bowser R, Kordower JH, Mufson EJ. 1997. A confocal microscopic analysis of galaninergic hyperinnervation of cholinergic basal forebrain neurons in Alzheimer's disease. Brain Pathol 7:723-730.
5. Branchek TA, Smith KE, Gerald C, Walker MW. 2000. Galanin receptor subtypes. Trends Pharmacol Sci 21:109-117.
6. Chan-Palay V. 1988. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia. J Comp Neurol 273:543-557.
7. Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ, Ashe KH. 2005. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 8:79-84.
8. Counts SE, Perez SE, Mufson EJ. 2008. Galanin in Alzheimer's disease: neuroinhibitory or neuroprotective? Cell Mol Life Sci 65:1842-1853.
9. Dickson DW. 2004. Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect? J Clin Invest 114:23-27.
10. Diez M, Danner S, Frey P, Sommer B, Staufenbiel M, Wiederhold KH, Hökfelt T. 2003. Neuropeptide alterations in the hippocampal formation and cortex of transgenic mice overexpressing beta-amyloid precursor protein (APP) with the Swedish double mutation (APP23). Neurobiol Dis 14:579-594.
11. Ding X, MacTavish D, Kar S. 2006. Galanin attenuates beta-amyloid (Abeta) toxicity in rat cholinergic basal forebrain neurons. Neurobiol Dis 21:413-420.
12. Doré S, Kar S, Quirion R. 1997. Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity. Proc Natl Acad Sci U S A 94:4772-4777.
13. Elliott-Hunt CR, Marsh B, Bacon A, Pope R, Vanderplank P, Wynick D. 2004. Galanin acts as a neuroprotective factor to the hippocampus. Proc Natl Acad Sci U S A 101:5105-5110.
14. Elliott-Hunt CR, Pope RJ, Vanderplank P, Wynick D. 2007. Activation of the galanin receptor 2 (GalR2) protects the hippocampus from neuronal damage. J Neurochem 100:780-789.
15. 25-35 inhibits glutamate uptake in cultured neurons and astrocytes: modulation of uptake as a survival mechanism. Neurobiol Dis 15:580-589.
16. Floden AM, Li S, Combs CK. 2005. Beta-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors. J Neurosci 25:2566-2575.
17. Forloni G, Chiesa R, Smiroldo S, Verga L, Salmona M, Tagliavini F, Angeretti N. 1993. Apoptosis mediated neurotoxicity induced by chronic application of β amyloid fragment 25-35. Neuroreport 4:523-526.
18. 25-35 toxicity in organotypic hippocampal slice cultures. Neurochem Res 34:295-303.
19. Gray CW, Patel AJ. 1995. Neurodegeneration mediated by glutamate and beta-amyloid peptide: a comparison and possible interaction. Brain Res 691:169-179.
20. 25-35) inhibits Na+-dependent glutamate uptake in rat hippocampal astrocyte cultures. J Neurochem 67: 277-286.
21. Harrison RS, Sharpe PC, Singh Y, Fairlie DP. 2007. Amyloid peptides and proteins in review. Rev Physiol Biochem Pharmacol 159:1-77.
22. Hartley DM, Walsh DM, Ye CPDiehl T, Vasquez S, Vassilev PM, Teplow DB, Selkoe DJ. 1999. Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci 19:8876-8884.
23. Heinitz K, Beck M, Schliebs R, Perez-Polo JR. 2006. Toxicity mediated by soluble oligomers of beta-amyloid(1-42) on cholinergic SN56.B5.G4 cells. J Neurochem 98:1930-1945.
24. Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S, Malinow R. 2006. AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 52:831-843.
25. Huang HM, Ou HC, Hsieh SJ. 2000. Antioxidants prevent amyloid peptide-induced apoptosis and alteration of calcium homeostasis in cultured cortical neurons. Life Sci 66:1879-1892.
26. Iismaa TP, Shine J. 1999. Galanin and galanin receptors. Results Probl Cell Differ 26:257-291.
27. Isaacs AM, Senn DB, Yuan M, Shine JP, Yankner BA. 2006. Acceleration of amyloid beta-peptide aggregation by physiological concentrations of calcium. J Biol Chem 281:27916-2723.
28. Jhamandas JH, MacTavish D. 2004. Antagonist of the amylin receptor blocks beta-amyloid toxicity in rat cholinergic basal forebrain neurons. J Neurosci 24:5579-5584.
29. Kordower JH, Le HK, Mufson EJ. 1992. Galanin immunoreactivity in the primate central nervous system. J Comp Neurol 319:479-500.
30. Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, Viola KL, Klein WL. 2007. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci 27:796-807.
31. LaFerla F. 2002. Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat Rev Neurosci 3:862-872.
32. Lee HJ, Hammond DN, Large TH, Wainer BH. 1990. Immortalized young adult neurons from the septal region: generation and characterization. Dev Brain Res 52:219-228.
33. Liu HX, Brumovsky P, Schmidt R, Brown W, Payza K, Hodzic L, Pou C, Godbout C, Hokfelt T. 2001. Receptor subtype-specific pronociceptive and analgesic actions of galanin in the spinal cord: selective actions via GalR1 and GalR2 receptors. Proc Natl Acad Sci U S A 98:9960-9964.
34. Lu X, Lundström L, Bartfai T. 2005. Galanin (2-11) binds to GalR3 in transfected cell lines: limitations for pharmacological definition of receptor subtypes. Neuropeptides 39:165-167.
35. Ma W, Zheng WH, Belanger S, Kar S, Quirion R. 2001. Effects of amyloid peptides on cell viability and expression of neuropeptides in cultured rat dorsal root ganglion neurons: a role for free radicals and protein kinase C. Eur J Neurosci 13:1125-1135.
36. Malik MA, Greenwood CE, Blusztajn JK, Berse B. 2000. Cholinergic differentiation triggered by blocking cell proliferation and treatment with all-trans-retinoic acid, Brain Res 874:178-185.
37. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE. 1992. Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12:376-389.
38. Maurice T, Lockhart BP, Privat A. 1996. Amnesia induced in mice by centrally administered Aβ-amyloid peptides involves cholinergic dysfunction. Brain Res 706:181-193.
39. McDonald MP, Crawley JN. 1997. Galanin-acetylcholine interactions in rodent memory tasks and Alzheimer's disease. J Psychiatry Neurosci 22: 303-317.
40. Melander T, Staines WA, Rökaeus A. 1986. Galanin-like immunoreactivity in hippocampal afferents in the rat, with special reference to cholinergic and noradrenergic inputs. Neuroscience 19:223-240.
41. Melander T, Köhler C, Nilsson S, Hökfelt T, Brodin E, Theodorsson E, Bartfai T. 1988. Autoradiographic quantitation and anatomical mapping of 125I-galanin binding sites in the rat central nervous system. J Chem Neuroanat 1:213-233.
42. Mufson EJ, Cochran E, Benzing W, Kordower JH. 1993. Galaninergic innervation of the cholinergic vertical limb of the diagonal band (Ch2) and bed nucleus of the stria terminalis in aging, Alzheimer's disease and Down's syndrome. Dementia 4:237-250.
43. Mufson EJ, Counts SE, Perez SE, Binder L. 2005 Galanin plasticity in the cholinergic basal forebrain in Alzheimer's disease and transgenic mice. Neuropeptides 39:233-237.
44. Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, Yuan J. 2000. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403:98-103.
45. Ögren SO, Hökfelt T, Kask K, Langel U, Bartfai T. 1992. Evidence for a role of the neuropeptide galanin in spatial learning. Neuroscience 51:1-5.
46. Pedersen WA, Kloczewiak MA, Blusztajn JK 1996. Amyloid beta-protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurons of the basal forebrain. Proc Natl Acad Sci U S A 93:8068-8071.
47. Pellistri F, Bucciantini M, Relini A, Nosi D, Gliozzi A, Robello M, Stefani M. 2008. Non-specific interaction of prefibrillar amyloid aggregates with glutamatergic receptors results in Ca2+ increase in primary neuronal cells. J Biol Chem 283:29950-29960.
48. Pereira C, Ferreiro E, Cardoso SM, de Oliveira CR. 2004. Cell degeneration induced by amyloid-beta peptides: implications for Alzheimer's disease. J Mol Neurosci 23:97-104.
49. Pérez SE, Wynick D, Steiner R, Mufson EJ. 2001. Distribution of galaninergic immunoreactivity in the brain of the mouse. J Comp Neurol 434:158-185.
50. Pike CJ, Walencewicz AJ, Glabe CG, Cotman CW. 1991. In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res 563:311-314.
51. 25-35 region to aggregation and neurotoxicity. J Neurochem. 64,253-265.
52. Pike CJ, Ramezan-Arab N, Cotman CW. 1997. β-Amyloid neurotoxicity in vitro: evidence of oxidative stress but not protection by antioxidants. J Neurochem. 69,1601-1611.
53. Pirondi S, Fernandez M, Schmidt R, Hökfelt T, Giardino L, Calzà L. 2005. The galanin-R2 agonist AR-M1896 reduces glutamate toxicity in primary neural hippocampal cells. J Neurochem 95:821-833.
54. Resende R, Pereira C, Agostinho P, Vieira AP, Malva JO, Oliveira CR. 2007. Susceptibility of hippocampal neurons to Abeta peptide toxicity is associated with perturbation of Ca2+ homeostasis. Brain Res 1143:11-21.
55. Rökaeus A, Melander T, Hökfelt T, Lundberg JM, Tatemoto K, Carlquist M, Mutt V. 1984. A galanin-like peptide in the central nervous system and intestine of the rat. Neurosci Lett 47:161-166.
56. Roth KA. 2001. Caspases, apoptosis, and Alzheimer disease: causation, correlation, and confusion. J Neuropathol Exp Neurol 60:829-838.
57. Sarang SS, Yoshida T, Cadet R, Valeras AS, Jensen RV, Gullans SR. 2002. Discovery of molecular mechanisms of neuroprotection using cell-based bioassays and oligonucleotide arrays. Physiol Genomics 11:45-52.
58. Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL. 2007. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 27:2866-2875.
59. Skofitsch G, Jacobowitz DM. 1985. Immunohistochemical mapping of galanin-like neurons in the rat central nervous system. Peptides 6:509-546.
60. Skofitsch G, Sills MA, Jacobowitz DM. 1986. Autoradiographic distribution of 125I-galanin binding sites in the rat central nervous system. Peptides 7:1029-1042.
61. Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, Nairn AC, Salter MW, Lombroso PJ, Gouras GK, Greengard P. 2005. Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 8:1051-1058.
62. Song MS, Rauw G, Baker GB, Kar S. 2008. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation. Eur J Neurosci 28:1989-2002.
63. Tatemoto K, Rökaeus A, Jörnvall H, McDonald TJ, Mutt V. 1983. Galanin - a novel biologically active peptide from porcine intestine. FEBS Lett 164:124-128.
64. Tofighi R, Joseph B, Xia S, Xu ZQ, Hamberger B, Hökfelt T, Ceccatelli S. 2008. Galanin decreases proliferation of PC12 cells and induces apoptosis via its subtype 2 receptor (GalR2). Proc Natl Acad Sci U S A 105:2717-2722.
65. Tremblay R, Chakravarthy B, Hewitt K, Tauskela J, Morley P, Atkinson T, Durkin JP. 2000. Transient NMDA receptor inactivation provides long-term protection to cultured cortical neurons from a variety of death signals. J Neurosci 20:7183-7192.
66. Walsh DT, Montero RM, Bresciani LG, Jen AY, Leclercq PD, Saunders D, EL-Amir AN, Gbadamoshi L, Gentleman SM, Jen LS. 2002. Amyloid-beta peptide is toxic to neurons in vivo via indirect mechanisms. Neurobiol Dis 10:20-27.
67. Xu J, Chen S, Ku G, Ahmed SH, Xu J, Chen H, Hsu CY. 2001. Amyloid beta peptide-induced cerebral endothelial cell death involves mitochondrial dysfunction and caspase activation. J Cereb Blood Flow Metab 21:702-710.